Investigation of PPCPs in wastewater treatment plants in Greece: Occurrence, removal and environmental risk assessment

被引:452
作者
Kosma, Christina I. [1 ]
Lambropoulou, Dimitra A. [2 ]
Albanis, Triantafyllos A. [1 ]
机构
[1] Univ Ioannina, Dept Chem, GR-45110 Ioannina, Greece
[2] Aristotle Univ Thessaloniki, Dept Chem, Thessaloniki 54124, Greece
关键词
Hospital wastewaters; LC-MS; LC-MS/LTQ-Orbitrap; Municipal wastewaters; PPCPs; Environmental risk assessment; PERSONAL CARE PRODUCTS; SEWAGE-TREATMENT PLANTS; PHARMACEUTICALLY ACTIVE COMPOUNDS; DIFFERENT THERAPEUTIC CLASSES; RESIDUE ANALYTICAL METHOD; TANDEM MASS-SPECTROMETRY; SOLID-PHASE EXTRACTION; ANTIINFLAMMATORY DRUGS; EMERGING CONTAMINANTS; SURFACE WATERS;
D O I
10.1016/j.scitotenv.2013.07.044
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
In the present work, an extensive study on the presence of eighteen pharmaceuticals and personal care products (PPCPs) in eight wastewater treatment plants (WWTPs) of Greece has been conducted. The study covered four sampling periods over 1-year, where samples (influents; effluents) from eight WWTPs of various cities in Greece were taken. All WWTPs investigated are equipped with conventional activated sludge treatment. A common pre-concentration step based on SPE was applied, followed by LC-UV/Vis-ESI-MS. Further confirmation of positive findings was accomplished by using LC coupled to a high resolution Orbitrap mass spectrometer. The results showed the occurrence of all target compounds in the wastewater samples with concentrations up to 96.65 mu g/L. Paracetamol, caffeine, trimethoprim, sulfamethoxazole, carbamazepine, diclofenac and salicylic acid were the dominant compounds, while tolfenamic acid, fenofibrate and simvastatin were the less frequently detected compounds with concentrations in effluents below the LOQ. The removal efficiencies showed that many WWTPs were unable to effectively remove most of the PPCPs investigated. Finally, the study provides an assessment of the environmental risk posed by their presence in wastewaters by means of the risk quotient (RQ). RQs were more than unity for various compounds in the effluents expressing possible threat for the aquatic environment. Tridosan was found to be the most critical compound in terms of contribution and environmental risk, concluding that it should be seriously considered as a candidate for regulatory monitoring and prioritization on a European scale on the basis of realistic PNECs. The results of the extensive monitoring study contributed to a better insight on PPCPs in Greece and their presence in influent and effluent wastewaters. Furthermore, the unequivocal identification of two transformation products of trimethoprim in real wastewaters by using the advantages of the LTQ Orbitrap capabilities provides information that should be taken into consideration in future PPCP monitoring studies in wastewaters. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:421 / 438
页数:18
相关论文
共 73 条
[21]   Multi-class determination of around 50 pharmaceuticals, including 26 antibiotics, in environmental and wastewater samples by ultra-high performance liquid chromatography-tandem mass spectrometry [J].
Gracia-Lor, Emma ;
Sancho, Juan V. ;
Hernandez, Felix .
JOURNAL OF CHROMATOGRAPHY A, 2011, 1218 (16) :2264-2275
[22]   Simultaneous determination of acidic, neutral and basic pharmaceuticals in urban wastewater by ultra high-pressure liquid chromatography-tandem mass spectrometry [J].
Gracia-Lor, Emma ;
Sancho, Juan V. ;
Hernandez, Felix .
JOURNAL OF CHROMATOGRAPHY A, 2010, 1217 (05) :622-632
[23]   Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters [J].
Gros, Meritxell ;
Petrovic, Mira ;
Barcelo, Damia .
TALANTA, 2006, 70 (04) :678-690
[24]   Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry [J].
Gros, Meritxell ;
Rodriguez-Mozaz, Sara ;
Barcelo, Damia .
JOURNAL OF CHROMATOGRAPHY A, 2012, 1248 :104-121
[25]   Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes [J].
Gros, Meritxell ;
Petrovic, Mira ;
Ginebreda, Antoni ;
Barcelo, Damia .
ENVIRONMENT INTERNATIONAL, 2010, 36 (01) :15-26
[26]   Tracing Pharmaceutical Residues of Different Therapeutic Classes in Environmental Waters by Using Liquid Chromatography/Quadrupole-Linear Ion Trap Mass Spectrometry and Automated Library Searching [J].
Gros, Meritxell ;
Petrovic, Mira ;
Barcelo, Damia .
ANALYTICAL CHEMISTRY, 2009, 81 (03) :898-912
[27]   Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline [J].
Grung, Merete ;
Kallqvist, Torsten ;
Sakshaug, Solveig ;
Skurtveit, Svetlana ;
Thomas, Kevin V. .
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2008, 71 (02) :328-340
[28]   Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments [J].
Hernando, MD ;
Mezcua, M ;
Fernández-Alba, AR ;
Barceló, D .
TALANTA, 2006, 69 (02) :334-342
[29]   Accurate mass screening and identification of emerging contaminants in environmental samples by liquid chromatography-hybrid linear ion trap Orbitrap mass spectrometry [J].
Hogenboom, A. C. ;
van Leerdam, J. A. ;
de Voogt, P. .
JOURNAL OF CHROMATOGRAPHY A, 2009, 1216 (03) :510-519
[30]   Chromatographic and mass spectral characterization of budesonide and a series of structurally related corticosteroids using LC-MS [J].
Hou, SG ;
Hindle, M ;
Byron, PR .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (1-2) :196-205